STOCK TITAN

Blade Air Mobility (BLDE) Stock Price, News & Analysis

BLDE NASDAQ

Ticker history: BLDE became SRTA (Strata Critical Medical, Inc.) on .

Published by Stock Titan Data refreshed

Price Move History

Daily moves over 5%
51 251 sessions, August 28, 2024 to August 28, 2025
Largest daily move
+18.5% close of May 12, 2025
1-year change
+54.6% closing prices, August 28, 2024 to August 28, 2025
1-month change
+8.4% closing prices, July 28, 2025 to August 28, 2025

Company Description

Blade Air Mobility, Inc. (NASDAQ: BLDE), which has changed its corporate name to Strata Critical Medical, Inc. as disclosed in SEC filings, has historically operated as a technology-powered air mobility platform. Under the BLDE ticker, the company combined aviation logistics with software and terminal infrastructure to provide air transportation and logistics services for both medical and passenger use.

According to multiple company press releases, Blade Air Mobility has provided air transportation and logistics for hospitals across the United States, where it is described as one of the largest transporters of human organs for transplant. In addition, it has provided passenger services using helicopter and fixed-wing aircraft, with routes and services focused primarily on the Northeast United States, Southern Europe and, at times, Western Canada. The company has been based in New York City and has emphasized an asset-light model, relying on third-party aircraft operators while focusing on logistics, technology, and customer interface.

Blade’s business model, as described in its news releases, has centered on coordinating and arranging flights operated by other entities, managing passenger terminal and lounge infrastructure in key urban markets, and providing time-sensitive medical logistics. Its proprietary technologies and exclusive passenger terminal infrastructure have been positioned to support a transition from traditional helicopters and fixed-wing aircraft to Electric Vertical Aircraft (EVA or eVTOL), with the stated goal of enabling quieter and emission-free air mobility.

Transition from Blade Air Mobility to Strata Critical Medical

Based on an August 29, 2025 Form 8-K, Blade Air Mobility, Inc. changed its name to Strata Critical Medical, Inc. and its Nasdaq trading symbol changed from BLDE to SRTA. The same filing explains that the company completed the previously announced sale of its Passenger business to a subsidiary of Joby Aviation, Inc. The transaction included Blade’s passenger operations and related assets, while the remaining public company continues under the Strata Critical Medical name.

In related press releases, the company has indicated that following the closing of the passenger divestiture, the remaining business would focus on mission critical logistics and medical services to hospitals and healthcare providers throughout the country. The medical division, which includes the Trinity Medical Solutions business, has been described as one of the largest air transporters of human organs for transplant in the United States. The company has also highlighted a long-term commercial relationship under which Joby’s aircraft may be used for medical transport services, reflecting an ongoing connection between advanced air mobility technology and Strata’s medical logistics operations.

Business Focus Under the BLDE Ticker

While trading as BLDE, Blade Air Mobility’s activities, as described in its public communications, included:

  • Medical air logistics: Providing transportation and logistics for hospitals across the United States, with a focus on the movement of human organs for transplant and related time-critical medical services.
  • Passenger air mobility: Offering, selling, promoting, marketing, planning, booking, brokering, coordinating and arranging transportation of passengers on aircraft operated by third parties, including helicopter and fixed-wing services in key urban and regional corridors.
  • Terminal and lounge infrastructure: Operating exclusive passenger terminal and lounge infrastructure in major urban markets to support its passenger air mobility services.
  • Technology platform: Using proprietary technologies to manage bookings, logistics, and operations, and to prepare for integration of Electric Vertical Aircraft (EVA/eVTOL) into its model.

The company has repeatedly described its approach as asset-light, reflecting its reliance on third-party aircraft operators rather than owning and operating the aircraft fleet itself. Its communications also emphasize the role of EVA/eVTOL technology in enabling quieter and emission-free air mobility, and the company has participated in demonstration flights with electric aircraft manufacturers to advance this objective.

Corporate Actions and Strategic Transactions

SEC filings and press releases indicate several notable corporate developments associated with the BLDE ticker:

  • Sale of Passenger Business: An Equity Purchase Agreement dated August 1, 2025, and subsequent Form 8-K filings describe the agreement for a subsidiary of Joby Aviation to acquire Blade’s passenger business. A Form 8-K dated August 29, 2025 reports completion of this sale and notes that the consideration was paid in Joby Aviation common stock, with potential additional contingent consideration based on specified performance and retention metrics.
  • Name and Ticker Change: The August 29, 2025 Form 8-K explains that the company amended its certificate of incorporation to change its name from Blade Air Mobility, Inc. to Strata Critical Medical, Inc. and that its Nasdaq trading symbol changed to SRTA at the market open on August 29, 2025.
  • Post-transaction focus: Company press releases describe the post-transaction entity (Strata Critical Medical) as a pure-play contractual healthcare and medical logistics business, with an emphasis on mission critical logistics and medical services for hospitals and healthcare providers, and with a long-term commercial agreement giving Joby a role in providing certain medical transport services.

Industry Classification

For industry classification purposes, BLDE has been associated with All Other Business Support Services within the broader Administrative and Support and Waste Management and Remediation Services sector. Its actual operating activities, as described in its public disclosures, have centered on aviation logistics, medical transport, and passenger air mobility, supported by a technology-enabled platform and dedicated terminal infrastructure.

BLDE as a Historical Ticker

Because the company’s legal name and trading symbol have changed, BLDE serves as a historical ticker for investors researching the period when the company operated as Blade Air Mobility, Inc. and combined both passenger and medical air mobility businesses. Current information about the renamed entity and its ongoing operations is associated with the Strata Critical Medical, Inc. (SRTA) listing, as indicated in the company’s SEC filings.

Stock Performance

$4.73
No recent trading
Last close: August 28, 2025
+54.6%
1 year to August 28, 2025

Blade Air Mobility (BLDE) closed at $4.73 on August 28, 2025. In the 12 months to August 28, 2025, the price gained 54.6%.

See what a $1,000 investment in BLDE would be worth today

Average down calculator for BLDE

BLDE Metrics & Rankings

Price returns through August 28, 2025. Month and year figures include the first trading day. Ranking links may use different dates.

Latest News

Blade Air Mobility has 10 recent news articles. Of the recent coverage, 6 articles coincided with positive price movement and 3 with negative movement. Key topics include conferences, earnings, acquisition. View all BLDE news →

Financial Highlights

Blade Air Mobility generated $197.1M in revenue in FY2025, retaining a 20.9% gross margin, operating income reached -$22.4M (-11.3% operating margin), and net income was $41.3M, reflecting a 21.0% net profit margin. Diluted earnings per share stood at $0.50. The company generated -$48.9M in operating cash flow. The current ratio was 6.38, measuring current assets divided by current liabilities.

$197.1M
Revenue (FY2025)
$41.3M
Net Income (FY2025)
-$48.9M
Operating Cash Flow

Upcoming Events

No upcoming events scheduled for BLDE.

BLDE Company Profile & Sector Positioning

Blade Air Mobility (BLDE) operates in the Airports & Air Services industry within the broader Industrials sector and is listed on the NASDAQ.

Investors comparing BLDE often look at related companies in the same sector, including Grupo Aeroportuario del Centro Norte S.A.B. de C.V (OMAB), Joby Aviation, Inc. (JOBY), Wheels Up Experience Inc. (UP), AerSale Corporation (ASLE), and Grupo Aeroportuario del Pacifico, S.A.B. de C.V. (PAC). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate BLDE's relative position within its industry.

Frequently Asked Questions

Blade Air Mobility (BLDE) has no recent trading. Its last close was $4.73 on August 28, 2025. The company now trades as SRTA.

The FY2025 revenue of Blade Air Mobility (BLDE) is $197.1M, from its most recent completed fiscal year.

The FY2025 net income of Blade Air Mobility (BLDE) is $41.3M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Blade Air Mobility (BLDE) is $0.50 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Blade Air Mobility (BLDE) is -$48.9M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The net profit margin of Blade Air Mobility (BLDE) is 21.0% for FY2025, its most recent completed fiscal year. Learn about profit margins.

The operating profit margin of Blade Air Mobility (BLDE) is -11.3% for FY2025, its most recent completed fiscal year. Learn about operating margins.

The gross profit margin of Blade Air Mobility (BLDE) is 20.9% for FY2025, its most recent completed fiscal year. Learn about gross margins.

The current ratio of Blade Air Mobility (BLDE), current assets divided by current liabilities, was 6.38 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of Blade Air Mobility (BLDE) is $41.1M for FY2025, its most recent completed fiscal year.

The operating income of Blade Air Mobility (BLDE) is -$22.4M for FY2025, its most recent completed fiscal year. Learn about operating income.

According to its press releases, Blade Air Mobility provided air transportation and logistics for hospitals across the United States, where it has been described as one of the largest transporters of human organs for transplant, and also arranged passenger flights using helicopter and fixed-wing services primarily in the Northeast United States, Southern Europe and, at times, Western Canada.

Company disclosures describe Blade’s model as asset-light, in which it offered, sold, planned, booked, brokered, coordinated and arranged transportation on aircraft operated by other entities, while focusing on logistics, proprietary technologies and exclusive passenger terminal infrastructure.

An August 29, 2025 Form 8-K reports that Blade Air Mobility, Inc. changed its name to Strata Critical Medical, Inc. The same filing notes that the company completed the sale of its Passenger business to a subsidiary of Joby Aviation, with the remaining public company continuing under the Strata Critical Medical name.

The August 29, 2025 Form 8-K states that at the market open on August 29, 2025, the company’s Nasdaq trading symbol changed from BLDE to SRTA in connection with its name change to Strata Critical Medical, Inc.

Company press releases explain that after the sale of the Passenger business to Joby Aviation, the remaining public company, rebranded as Strata Critical Medical, focuses on mission critical logistics and medical services to hospitals and healthcare providers throughout the country, including the Trinity Medical Solutions business that transports human organs for transplant.

Blade’s public communications state that its asset-light model, exclusive passenger terminal infrastructure and proprietary technologies are designed to facilitate a transition from helicopters and fixed-wing aircraft to Electric Vertical Aircraft (EVA or eVTOL), with the goal of enabling quieter and emission-free air mobility. Press releases also reference a long-term partnership giving Strata access to Joby eVTOLs for medical use.

Multiple press releases describe Blade Air Mobility as being based in New York City.

A company press release dated August 4, 2025 and subsequent Form 8-K filings explain that Blade’s Passenger division is being sold to Joby Aviation and that the divestiture includes the passenger operations and the Blade brand. The remaining public company, renamed Strata Critical Medical, focuses on medical logistics and services rather than the passenger business.